Literature DB >> 3396115

Pharmacokinetics of PTT-119 in man.

F Pannuti1, G Coppi, F Borella, A Martoni, L Urbano, B Melotti.   

Abstract

The pharmacokinetics of PTT-119, a new alkylating agent, was studied in 8 advanced cancer patients. PTT-119 disappeared rapidly from plasma after administration at a dose of 3 mg/kg by i.v. bolus injection. The HPLC method shows plasma levels of m-bis (dichloroethyl)amino-phenyl-L-alanine which is the major metabolite of PPT-119. Elimination of the drug from plasma can be described by a one-compartment model. Mean values of 77.8 min for the half-life, 510.8 ml/min for the total plasma clearance and 0.69 l/kg for the volume of distribution were found.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396115

Source DB:  PubMed          Journal:  Chemioterapia        ISSN: 0392-906X


  1 in total

1.  Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma.

Authors:  G Visani; R M Lemoli; P Tosi; F Verlicchi; B Gamberi; A R Cenacchi; R Colombini; M Fogli; D Russo; E Zuffa
Journal:  Blut       Date:  1990-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.